An essential discussion to the future of business, The Coming Biotech Age describes the biotech revolution taking place within our leading universities, corporations and government. Without daunting scientific jargon, Oliver reveals what everyone ­ CESs, investors, policymakers and others interested in the social ramifications of bioterials ­ must know, for instance:

• How the biotech lab is becoming a GeneFactory ­ with the mass production of healthcare products and agricultural biotech
  
• How the Bioterial Age will fundamentally alter the laws of economics as we know them
  
• How biotechnology is changing the actual structure of the corporation
  

Oliver also takes a look at the biovisionaries ­ researchers, scientists and business leaders ­ behind the biotech movement, and the biocapitalists who are poised to cash in on the new era.

A unique focus of The Coming Biotech Age is the positive effects that biotech will have on the global economy. Global chemical suppliers (DuPont, Novatis, Monsanto) are reinventing themselves as biotech firms, joining over 4000 biotechnology organizations around the world. while Oliver does discuss potential dangers of biotechnologies, he also points out the tremendous advances biotech has brought:

• Over 100 million people worldwide have been helped by the development of new biotechnology products and vaccines.
  
• Hundreds of biotechnology products and vaccines currently in human clinical trials and the hundreds more in early development with the potential to help millions more
  

In The Coming Biotech Age you'll read about these remarkable bioterial developments: pharmaceuticals tailored to an individual's genetic makeup ... babies made healthy through genetic modification ... pest- and disease-resistant food ... "smart" materials that mimic human processes ... endless solar energy machines... and many more. Oliver places these developments within an economic context, explaining what these advances will mean to the global business community.

The potential for bioterials is tremendous­­and infinite. If you're in business you cannot afford to miss The Coming Biotech Age. Truly, your company's future will depend on it.

"I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most importantly, where it's going."

­­Scott W. Morrison, Partner, Ernst & Young LLP.

"Timely insights into an industry about to emerge as the single most important driver of the 21st century; knowledge-based economy with breakthrough discoveries that will yield unprecedented advances in our battle to combat disease and benefit humankind."

­­Dr. Francesco Bellini, CEO, BioChem Pharma.

"Every business leader must be thinking about the potential transformation from 'e-commerce' to bioterial commerce!"

­­James Harper, President, Diabetes and Growth Products, Eli Lilly & Co.

"A readable, timely, forward-looking and provocative book. A must read for anyone interested to understand, or profit from, an industry that will change the dynamics of our economy in the 21st century."

­­Alicia Loffer, Ph.D., Director, Northwestern University, Center for Biotechnology

"Anyone who speculates about the future (and who among us doesn't ) must arm themselves with the perspectives in Oliver's provocative look at the next twenty years."

­­John C. Sorenson, President, Novartis Seeds, Inc.

"A remarkably astute overview, both balanced and informative, of how the rapid evolution of biotechnology is paving the way for bioterials."

­­Joyce Groote, President, BIOTECanada.

"I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most importantly, where it's going."--Scott W. Morrison, partner, Ernst & Young LL

Richard W. Oliver predicted the onset of a new era with The Coming Biotech Age. Now that age is here--and companies are reaping the benefits of this incredible new revolution. As biotech companies become the new economic engines of growth and innovation, businesses must have access to the latest developments of this area of research.

In a special revised edition, now titled The Biotech Age, Oliver has created the first practical guide to this fascinating realm of scientific development. With updated information on the latest research, examples of biotech breakthroughs, and a close examination of current biotech issues such as cloning and stem cell research, The Biotech Age presents an accessible overview of the business of biotechnology and its vast implications and opportunities for all types of industries.

This is a topic no one can afford to miss--especially future-minded executives and investors in cutting-edge technologies.

Richard Oliver, author of the acclaimed The Shape of Things to Come, has created the first practical guide to the Biotech Age. Rather than focusing on science or social issues, he presents an accessible overview of the business of biotechnology and its vast implications and opportunities for all types of industries. Like the Internet, this is a topic few can afford to miss out on­­especially future-minded executives and investors in cutting-edge technologies.